Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2013 1
2015 2
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

4 results
Results by year
Filters applied: . Clear all
Page 1
Early Phase in the Development of Cannabidiol as a Treatment for Addiction: Opioid Relapse Takes Initial Center Stage.
Hurd YL, Yoon M, Manini AF, Hernandez S, Olmedo R, Ostman M, Jutras-Aswad D. Hurd YL, et al. Neurotherapeutics. 2015 Oct;12(4):807-15. doi: 10.1007/s13311-015-0373-7. Neurotherapeutics. 2015. PMID: 26269227 Free PMC article. Review.
Safety and pharmacokinetics of oral cannabidiol when administered concomitantly with intravenous fentanyl in humans.
Manini AF, Yiannoulos G, Bergamaschi MM, Hernandez S, Olmedo R, Barnes AJ, Winkel G, Sinha R, Jutras-Aswad D, Huestis MA, Hurd YL. Manini AF, et al. J Addict Med. 2015 May-Jun;9(3):204-10. doi: 10.1097/ADM.0000000000000118. J Addict Med. 2015. PMID: 25748562 Free PMC article. Clinical Trial.
Cannabidiol, a nonpsychotropic component of cannabis, inhibits cue-induced heroin seeking and normalizes discrete mesolimbic neuronal disturbances.
Ren Y, Whittard J, Higuera-Matas A, Morris CV, Hurd YL. Ren Y, et al. J Neurosci. 2009 Nov 25;29(47):14764-9. doi: 10.1523/JNEUROSCI.4291-09.2009. J Neurosci. 2009. PMID: 19940171 Free PMC article.
Impact of enzymatic and alkaline hydrolysis on CBD concentration in urine.
Bergamaschi MM, Barnes A, Queiroz RH, Hurd YL, Huestis MA. Bergamaschi MM, et al. Anal Bioanal Chem. 2013 May;405(14):4679-89. doi: 10.1007/s00216-013-6837-x. Epub 2013 Mar 15. Anal Bioanal Chem. 2013. PMID: 23494274 Free PMC article.
Feedback